Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 2906
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00099879 | Study of BMS-275183 in Patients With Pre-treated Non-small Cell Lung Cancer | ||
| NCT01146327 | A Multiple Dose Study Of PF-04620110 In Healthy Overweight Or Obese Subjects | ||
| NCT02551861 | A Randomized, Open-Label Study of Daclatasvir and Sofosbuvir With or Without Ribavirin for 8 Weeks in Treatment-Naïve, Non-cirrhotic Subjects Infected With Chronic Hepatitis C Virus (HCV) Genotype 3 | ||
| NCT02932969 | Study With Healthy Japanese and Non-Asian Participants With BMS-986231 | ||
| NCT00857246 | Pre-operation Chemo and Antibody Therapy Followed by Surgical Resection and Adjuvant Chemoradiation for Gastric Cancer | ||
| NCT00312754 | A Phase IV Study of BMS-232632 in HIV+ Patients With Metabolic Syndrome | ||
| NCT00909766 | Safety, Pharmacokinetics and Pharmacodynamics Study to Evaluate BMS-830216 in Obese Subjects | ||
| NCT00362466 | A Study of Dasatinib vs. High-Dose Imatinib (600 mg) in Patients With Chronic Phase Chronic Myeloid Leukemia (CML) Who Failed to Achieve Complete Cytogenetic Response After 3-18 Months of Imatinib Therapy | ||
| NCT04671953 | Effect of BMS-986165 on the Blood Levels of Metformin | ||
| NCT01306942 | Dasatinib In Combination With Trastuzumab And Paclitaxel In First Line Treatment Of Her2-Positive MBC Patients | ||
| NCT03696069 | A Study is to Understand the Treatment Patterns for Immunotherapy Agents and BRAF/MEK Inhibitors Used in the Treatment of Advanced Melanoma | ||
| NCT04167462 | An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo in Participants With Plaque Psoriasis (POETYK-PSO-3) in Mainland China, Taiwan, and South Korea | ||
| NCT01581203 | Phase III Hallmark DUAL: ASV+DCV (Nulls/Partials, Intolerants/Ineligibles. Naives) | ||
| NCT01392703 | Pharmacokinetic Study Comparing Blood Levels of Dasatinib in Healthy Participants Who Received the Tablet Formulation With Those Who Received Liquid and Tablet-dispersed Formulations | ||
| NCT04126070 | Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors | ||
| NCT00337805 | Double Blind Randomized Trial of Saline vs Pentaspan for Resuscitation After Cardiac Surgery | ||
| NCT02863523 | COMRADE: Collaborative Care Management for Distress and Depression in Rural Diabetes | ||
| NCT03030261 | Elotuzumab, Pomalidomide, & Dexamethasone (Elo-Pom-Dex) With Second Autologous Stem Cell Transplantation for Relapsed Multiple Myeloma | ||
| NCT00252005 | Oral Direct Factor Xa-inhibitor Apixaban in Patients With Acute Symptomatic Deep-vein Thrombosis-The Botticelli DVT Study | ||
| NCT01707394 | Study to Evaluate a Single Dose of Apixaban in Pediatric Participants at Risk for a Thrombotic Disorder | ||
| NCT00319735 | Cetuximab and Radiation Therapy for Surgically Resectable Esophageal and Gastroesophageal (GE) Junction Carcinomas | ||
| NCT00214435 | Once Daily 3TC, Efavirenz and ddI for HIV Infection | ||
| NCT03192943 | A Study of BMS-986205 Given in Combination With Nivolumab in Patients With Advanced Tumors | ||
| NCT02227550 | Apixaban During Atrial Fibrillation Catheter Ablation: Comparison to Vitamin K Antagonist Therapy | ||
| NCT03865082 | Study of Tilsotolimod in Combination With Nivolumab and Ipilimumab for the Treatment of Solid Tumors (ILLUMINATE-206) | ||
| NCT01525823 | Assessment of Blood Glucose Changes in Healthy Volunteers After BMS-754807 Alone or BMS-754807 With Metformin | ||
| NCT07100080 | Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01) | ||
| NCT00554450 | Renal Impairment in Type 2 Diabetic Subjects | ||
| NCT02705989 | Safety, Tolerability and Relative Bioavailability Study of BMS-986195 in Healthy Subjects | ||
| NCT04513678 | Development of ImmunOncoTool | ||
| NCT03126617 | Expanded Access to Elotuzumab (Empliciti) for Multiple Myeloma | ||
| NCT07073690 | Treatment Patterns and Outcomes in Patients With Lower-risk Myelodysplastic Syndromes Treated With Luspatercept in China | ||
| NCT01088360 | Safety Study of Abatacept to Treat Rheumatoid Arthritis (B) | ||
| NCT03149120 | Study of Nivolumab With or Without Pazopanib in Metastatic or Unresectable Soft Tissue Sarcomas | ||
| NCT02335918 | A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors | ||
| NCT03273790 | A Retrospective Study of the Effectiveness and Safety of Nivolumab in Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients in Japan | ||
| NCT03698513 | A Study to Assess Administration of an Oral Anti-thrombotic With Antiplatelet Therapy in Healthy Subjects | ||
| NCT03607890 | Study of Nivolumab and Relatlimab in Advanced Mismatch Repair Deficient Cancers Resistant to Prior PD-(L)1 Inhibitor | ||
| NCT00739960 | Safety Study of Abatacept to Treat Refractory Sarcoidosis | ||
| NCT00437424 | A Study of Brivanib (BMS-582664) in Patients With Liver Cancer and Mild, Moderate or Severe Liver Dysfunction | ||
| NCT01420770 | Phase 2 Study of SAR302503 in Patients With Myelofibrosis | ||
| NCT06388369 | Neoadjuvant Lu-PSMA Radioligand Therapy and Ipilimumab in Men With Very High-risk Prostate Cancer | ||
| NCT03447990 | v4 Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-491 | ||
| NCT03061188 | Phase I/Ib Study of Nivolumab & Veliparib in Patients With Advanced Solid Tumors & Lymphoma | ||
| NCT05244070 | A Study to Evaluate the Safety and Tolerability of BMS-986403 in Participants With Relapsed and/or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | ||
| NCT03001882 | An Exploratory Study of the Effects of Nivolumab Combined With Ipilimumab in Patients With Treatment-Naive Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC) | ||
| NCT03215927 | Abatacept for the Treatment of Myositis-associated Interstitial Lung Disease | ||
| NCT02108860 | Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's) | ||
| NCT01460160 | Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia | ||
| NCT01592370 | An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma |
